- Janjigian, Y., Al-Batran, S., Wainberg, Z., Van Cutsem, E., Molena, D., Muro, K.,…Tabernero, J. (2024). Pathological complete response (pCR) to 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) with or without durvalumab (D) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study. Journal of Clinical Oncology, 42, 245-246. https://doi.org/10.1200/JCO.2024.42.3_suppl.LBA246 (Meeting abstract)
Pathological complete response (pCR) to 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) with or without durvalumab (D) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study
on 11 de novembre de 2024
with No hi ha comentaris
Deixa un comentari